Preliminary exploration of PSMA CAR-T combined with GD2 CAR-T for the treatment of refractory/relapsed gliomas
Abstract Background This study aimed to investigate the safety and efficacy of fourth-generation combined PSMA and GD2-targeted chimeric antigen receptor (CAR)-T cells in the treatment of refractory/relapsed gliomas. Method This study employed a single-arm design, enrolling patients with confirmed r...
Saved in:
| Main Authors: | Jinshan Gu, Jiasheng Li, Yang Xu, Ge Zhang, Jingyi Xie, Rui Jia, Wei Chen, Zhengfeng Lu, Chengwei Chang, Haijun Wen, Lung-ji Chang, Huajuan Ma, Qichun Cai |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-05-01
|
| Series: | Journal of Translational Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12967-025-06523-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CAR-T Cell Therapy for Acute Myeloid Leukemia: Where Do We Stand Now?
by: Pilar Lloret-Madrid, et al.
Published: (2025-05-01) -
GD2 targeting CAR T cells for neuroblastoma
by: John Anderson, et al.
Published: (2024-12-01) -
Be cautious to adopt a second CAR T-cell infusion after failure of CD19/CD22 cocktail CAR T-cell therapy in relapsed/refractory B-NHL
by: Gaoxiang Wang, et al.
Published: (2025-03-01) -
FUNCTIONAL ACTIVITY OF ANTI-GD2 CAR-T CELLS WITH DIFFERENT ANTIGEN-RECOGNITION MODULE
by: Dzmitry Lutskovich, et al.
Published: (2019-08-01) -
BCMA CAR-T therapy combined with pomalidomide is a safe and effective treatment for relapsed/refractory multiple myeloma
by: Yuhan Yan, et al.
Published: (2024-11-01)